Clinical Trials Logo

Clinical Trial Summary

this study is evaluating the safety and efficacy of ascorbic acid as a drug that can decrease inflammatory complications post surgical in addition to its impact on decreasing risk of arrhythmia and total opioid administration post operative


Clinical Trial Description

The study will include two arm of patients who are scheduled for elective cardiac surgery, either coronary artery bypass grafting (CABG) or Valvular replacement First arm: Patients will take 2 g orally ascorbic acid effervescent tablets the night before cardiac surgery, then 1 g twice daily for 5 days after surgery in addition to their traditional medical care. Second arm: will not be given ascorbic acid , instead a placebo 9orange carbonated beverage) will be used, and will be given the rest of traditional medical care provided to the first arm. Inflammatory markers C- reactive protein (CRP), erythrocyte sedimentation rate (ESR) and differential total leukocytic count (TLC), serum urea and creatinine, ALT, AST, CK-mb, CK-Total, aPTT, INR, Hemoglobin, platelet count, will be assessed on day 0, 1,2,4,6 postoperative in both arms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03639519
Study type Interventional
Source El- Galaa Military Medical Compound
Contact Tamer M Ayed, MD
Phone 01006045615
Email Tamerayed70@gmail.com
Status Recruiting
Phase Phase 4
Start date April 15, 2018
Completion date August 15, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05968456 - Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
Enrolling by invitation NCT04065919 - Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery Phase 4
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Terminated NCT01897519 - A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery Phase 2
Completed NCT01847859 - Pocket-size Ultrasound by Nurses in Cardiothoracic Post-operative Patients N/A
Recruiting NCT02863250 - Australian and New Zealand Massive Transfusion Registry
Completed NCT03725098 - Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations N/A
Terminated NCT00075179 - Natrecor in Pulmonary Hypertension Phase 4
Recruiting NCT02029534 - Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF) Phase 4